Graziella Pompei
Overview
Explore the profile of Graziella Pompei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gill K, Mills G, Wang W, Pompei G, Kunadian V
Expert Rev Cardiovasc Ther
. 2025 Mar;
:1-14.
PMID: 40056095
Introduction: Invasive management of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) should be considered regardless of age, but a key challenge is deciding which patients are most likely to benefit from...
2.
Rubino F, Pompei G, Mills G, Kotanidis C, Laudani C, Bendz B, et al.
Eur Heart J Open
. 2024 Dec;
4(6):oeae093.
PMID: 39698149
Aims: Women and older patients are underrepresented in randomized controlled trials (RCTs) investigating treatment strategies following acute coronary syndrome. This study aims to evaluate the benefit of invasive vs. conservative...
3.
4.
Ganzorig N, Pompei G, Jenkins K, Wang W, Rubino F, Gill K, et al.
AsiaIntervention
. 2024 Sep;
10(3):157-168.
PMID: 39347110
Multivessel coronary artery disease (CAD), defined as ≥50% stenosis in 2 or more epicardial arteries, is associated with a high burden of morbidity and mortality in acute coronary syndrome (ACS)...
5.
Tayal U, Pompei G, Wilkinson I, Adamson D, Sinha A, Hildick-Smith D, et al.
Heart
. 2024 Sep;
110(22):e4.
PMID: 39317437
Despite significant progress in cardiovascular pharmacotherapy and interventional strategies, cardiovascular disease (CVD), in particular ischaemic heart disease, remains the leading cause of morbidity and mortality among women in the UK...
6.
Pompei G, Ganzorig N, Kotanidis C, Alkhalil M, Collet C, Sinha A, et al.
Am J Prev Cardiol
. 2024 Aug;
19:100712.
PMID: 39161975
The mechanism underlying ischaemic heart disease (IHD) has been primarily attributed to obstructive coronary artery disease (CAD). However, non-obstructive coronary arteries are identified in >50% of patients undergoing elective coronary...
7.
Tebaldi M, Gallo F, Scoccia A, Durante A, Tedeschi D, Verdoliva S, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(2):62.
PMID: 39077421
Background: Recently, questions around the efficacy and effectiveness of Fractional Flow Reserve (FFR) have arisen in various clinical settings. Methods: The Clinical Outcome of FFR-guided Revascularization Strategy of Coronary Lesions...
8.
Rubino F, Brugaletta S, Mills G, Pompei G, Scarsini R, Ribichini F, et al.
Rev Cardiovasc Med
. 2024 Jul;
25(5):168.
PMID: 39076483
Background: Lesions with thin-cap fibroatheroma (TCFA), small luminal area and large plaque burden (PB) have been considered at high risk of cardiovascular events. Older patients were not represented in studies...
9.
Ruggiero R, Beneduce A, Demola P, Pompei G, Barioli A, Ryan N, et al.
G Ital Cardiol (Rome)
. 2024 Jun;
25(6 Suppl 1):41S-42S.
PMID: 38912746
No abstract available.
10.
Dirjayanto V, Martin-Ruiz C, Pompei G, Rubino F, Kunadian V
Int J Cardiol
. 2024 May;
409:132177.
PMID: 38761976
Background: The prognostic significance of inflammatory markers on the long-term risk of major adverse cardiovascular and cerebrovascular events (MACCE) in older NSTEACS patients remains unclear. Methods: NSTEACS patients aged 75...